IPCEF1: A Potential Drug Target and Biomarker (G26034)

Target Name: IPCEF1

NCBI ID: G26034

IPCEF1

Other Name(s): Interaction protein for cytohesin exchange factors 1, transcript variant 1 | PIP3-E | KIAA0403 | Interactor protein for cytohesin exchange factors 1 (isoform 1) | interaction protein for cytohesin exchange factors 1 Interaction protein for cytohesin exchange factors 1 | Phosphoinositide-binding protein PIP3-E | ICEF1_HUMAN | IPCEF1 variant 1 | Interactor protein for cytohesin exchange factors 1 | Interaction protein for cytohesin exchange factors 1 Interaction protein for cytohesin exchange factors 1 | Phosphoinositide binding protein PIP3-E | PIP3E | RP3-402L9.2 | phosphoinositide-binding protein PIP3-E | interaction protein for cytohesin exchange factors 1

IPCEF1: A Potential Drug Target and Biomarker

Cytoh茅sin exchange factors (CXFs) are a family of proteins that play a crucial role in intracellular signaling. These proteins are involved in the delivery of various cell organelles, including mitochondria, endoplasmic reticulum, and the endoplasmic reticulum. IPCEF1, also known as interaction protein for cytohesin exchange factors 1, is a protein that belongs to the CXF family. In this article, we will discuss IPCEF1, its function, potential drug targets, and potential biomarkers.

Function

IPCEF1 is a 21-kDa protein that is expressed in various cell types, including muscle, heart, and brain. It is involved in the delivery of mitochondria to the endoplasmic reticulum (ER) via the cytoskeleton. In addition to its role in mitochondrial delivery , IPCEF1 is also involved in the delivery of other organelles, including endoplasmic reticulum (ER) and the endoplasmic reticulum (ER).

Potential Drug Targets

IPCEF1 is a protein that can be targeted by small molecules due to its unique structure. It has a split domain structure, with the N-terminus containing a putative N-methylated arginine residue (ARG) and the C-terminus containing a putative Gly- Arg-Ser-Gly-Arg-Ser-Gly sequence. This structural domain provides a potential target for small molecules that can modulate the activity of IPCEF1.

In addition to its structural domain, IPCEF1 has several potential drug targets. One of these targets is the interaction between IPCEF1 and its partner protein, cytohesin exchange factor (CXF), which is a protein that is involved in the delivery of cytohermin to the endoplasmic reticulum. IPCEF1 has been shown to interact with CXF and can modulate its activity. Therefore, small molecules that can modulate the activity of IPCEF1 may also be useful as targets for drug development.

Potential Biomarkers

IPCEF1 is involved in the delivery of various cell organelles, including mitochondria, endoplasmic reticulum, and the endoplasmic reticulum. Therefore, it may be a useful biomarker for the diagnosis and prognosis of various diseases. For example, changes in the expression level of IPCEF1 may be associated with the development of certain diseases, such as cancer. Additionally, changes in IPCEF1 expression levels may also be an indicator of disease progression in diseases, such as heart disease.

Conclusion

In conclusion, IPCEF1 is a protein that is involved in the delivery of various cell organelles. Its unique structure and involvement in the delivery of mitochondria make it a potential drug target. Additionally, its involvement in the delivery of other organelles, including endoplasmic reticulum, makes it a potential biomarker for various diseases. Further research is needed to fully understand the role of IPCEF1 in cell signaling and its potential as a drug target and biomarker.

Protein Name: Interaction Protein For Cytohesin Exchange Factors 1

Functions: Enhances the promotion of guanine-nucleotide exchange by PSCD2 on ARF6 in a concentration-dependent manner

The "IPCEF1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about IPCEF1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets